Published in Lancet Diabetes Endocrinol on May 16, 2014
Whole Exome Sequencing in CKD Hypertension (WESCH) | NCT03718585
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet (2016) 4.80
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet (2016) 2.44
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol (2015) 1.66
Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries. JAMA Psychiatry (2016) 1.65
Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study. Cardiovasc Diabetol (2017) 1.37
High serum cholesterol: a missed risk factor for chronic kidney disease mortality. Lancet Diabetes Endocrinol (2014) 1.09
Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol (2015) 1.00
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol (2017) 0.92
Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Drug Des Devel Ther (2017) 0.89
Contribution of modifiable risk factors for hypertension and type-2 diabetes in Peruvian resource-limited settings. J Epidemiol Community Health (2015) 0.82
Ethnic differences in sleep duration and morning-evening type in a population sample. Chronobiol Int (2015) 0.80
Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. Biochim Biophys Acta (2016) 0.79
Thyroid function is associated with insulin resistance markers in healthy adolescents with risk factors to develop diabetes. Diabetol Metab Syndr (2015) 0.79
Discordant associations of lipid parameters with albuminuria and chronic kidney disease: a population-based study. Lipids Health Dis (2015) 0.79
Rural-to-urban migration and risk of hypertension: longitudinal results of the PERU MIGRANT study. J Hum Hypertens (2016) 0.79
High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25-64 Years Old Iranian Population. Int J Prev Med (2016) 0.78
Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling. Front Physiol (2015) 0.78
Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis. Biosci Rep (2016) 0.77
A pilot study of a Community Health Agent-led type 2 diabetes self-management program using Motivational Interviewing-based approaches in a public primary care center in São Paulo, Brazil. BMC Health Serv Res (2017) 0.77
Association of serum bisphenol a with hypertension in thai population. Int J Hypertens (2015) 0.77
Toxic stress, inflammation and symptomatology of chronic complications in diabetes. World J Diabetes (2015) 0.77
Dietary intake of subjects with diabetes is inadequate in Switzerland: the CoLaus study. Eur J Nutr (2016) 0.76
Mortality Attributable to Excess Body Mass Index in Iran: Implementation of the Comparative Risk Assessment Methodology. Int J Prev Med (2015) 0.76
Prognostic Value of Reverse Dipper Blood Pressure Pattern in Chronic Kidney Disease Patients not Undergoing Dialysis: Prospective Cohort Study. Sci Rep (2016) 0.75
Association of Parental Overweight and Cardiometabolic Diseases and Pediatric Adiposity and Lifestyle Factors with Cardiovascular Risk Factor Clustering in Adolescents. Nutrients (2016) 0.75
Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study. Cardiovasc Diabetol (2017) 0.75
Decreased renal function and associated factors in cities, towns and rural areas of Tanzania: a community-based population survey. Trop Med Int Health (2015) 0.75
High serum cholesterol: a missed risk factor for chronic kidney disease mortality--authors' reply. Lancet Diabetes Endocrinol (2014) 0.75
Secondary Data Analysis of National Surveys in Japan Toward Improving Population Health. J Epidemiol (2016) 0.75
Global Shifts in Cardiovascular Disease, the Epidemiologic Transition, and Other Contributing Factors: Toward a New Practice of Global Health Cardiology. Cardiol Clin (2017) 0.75
Cardiometabolic risk in young adults from northern Mexico: Revisiting body mass index and waist-circumference as predictors. BMC Public Health (2016) 0.75
Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. BMC Nephrol (2017) 0.75
Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol (2017) 0.75
Barriers that practitioners face when initiating insulin therapy in general practice settings and how they can be overcome. World J Diabetes (2017) 0.75
Vitamin D and retinal microvascular damage: The Rotterdam Study. Medicine (Baltimore) (2016) 0.75
Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease. J Am Heart Assoc (2016) 0.75
Chronic disease risk factors among hotel workers. Indian J Occup Environ Med (2016) 0.75
Put pressure worldwide on blood pressure control. J Thorac Dis (2016) 0.75
Prevalence, awareness, treatment and control of diabetes and impaired fasting glucose in the Southern Cone of Latin America. PLoS One (2017) 0.75
Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia. Cardiovasc Diabetol (2017) 0.75
A population-based national estimate of the prevalence and risk factors associated with hypertension in Rwanda: implications for prevention and control. BMC Public Health (2017) 0.75
Altered postcapillary and collecting venular reactivity in skeletal muscle with metabolic syndrome. J Physiol (2017) 0.75
Substantial Inter-Subject Variability in Blood Pressure Responses to Glucose in a Healthy, Non-obese Population. Front Physiol (2017) 0.75
High burden of hypertension across the age groups among residents of Gondar city in Ethiopia: a population based cross sectional study. BMC Public Health (2017) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet (2009) 10.55
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med (2008) 9.31
Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc (2007) 8.48
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens (2008) 6.82
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55
Changing the future of obesity: science, policy, and action. Lancet (2011) 5.56
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA (2013) 5.19
Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol (2004) 4.67
Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes (Lond) (2005) 4.41
Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet (2008) 4.32
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 4.19
Inequalities in non-communicable diseases and effective responses. Lancet (2013) 4.18
Role of smoking in global and regional cardiovascular mortality. Circulation (2005) 3.57
Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med (2013) 2.99
Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med (2008) 2.83
Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care (2004) 2.77
Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.66
Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust (2008) 2.63
Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open (2013) 2.40
Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science (2012) 2.00
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One (2013) 1.95
National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr (2011) 1.81
The promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States. PLoS Med (2010) 1.78
Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med (2012) 1.70
Understanding the decline of mean systolic blood pressure in Japan: an analysis of pooled data from the National Nutrition Survey, 1986-2002. Bull World Health Organ (2008) 1.43
A comparative risk assessment for South Africa in 2000: towards promoting health and preventing disease. S Afr Med J (2007) 1.37
Trends in dietary fat and cigarette smoking and the decline in coronary heart disease in New Zealand. Int J Epidemiol (1987) 1.36
Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev Med (1996) 1.33
Health in all policies-the Finnish initiative: background, principles, and current issues. Annu Rev Public Health (2010) 1.32
The contributions of risk factor trends to cardiometabolic mortality decline in 26 industrialized countries. Int J Epidemiol (2013) 1.08
The effects of a reduced-sodium, high-potassium salt substitute on food taste and acceptability in rural northern China. Br J Nutr (2008) 1.07
Blood pressure monitoring and control by cardiovascular disease status in UK primary care: 10 year retrospective cohort study 1998-2007. J Public Health (Oxf) (2010) 0.97
Antihypertensive drug treatment: the potential, expected and observed effects on vascular disease. J Hypertens Suppl (1990) 0.95